Navigation Links
Morphotek®, Inc. Announces Initiation of MORAb-004 Phase 2 Study in Metastatic Colorectal Cancer
Date:4/16/2012

EXTON, Pa., April 16, 2012 /PRNewswire/ -- Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 in the treatment of metastatic colorectal cancer that is refractory to all standard therapy. MORAb-004 is a monoclonal antibody that specifically binds to endosialin/tumor endothelial marker-1 (TEM-1).

The trial is a randomized, double-blind, placebo-controlled study to assess the efficacy and safety of single agent MORAb-004 plus best supportive care as determined by progression-free survival in patients with chemorefractory metastatic colorectal cancer. Secondary objectives include assessment of an overall survival benefit, identification of biomarkers to predict efficacy, and safety of single agent MORAb-004.

Morphotek expects to enroll up to 160 patients in this study, which is being conducted at clinical centers in the United States.  As part of the trial, patient tumors and plasma samples will be tested for endosialin/TEM-1 and/or proteins within its pathway to determine if the pattern of expression relates to or determines clinical effect. The goal of these investigations is to identify those patients who had a clinically meaningful response to MORAb-004.

"We are excited to have initiated this Phase II study of MORAb-004 in metastatic colorectal cancer," stated Christina Coughlin, M.D., Ph.D., Senior Director of Clinical Development at Morphotek. "New agents are needed for the treatment of metastatic colorectal cancer.  The treatment of chemorefractory colorectal cancer remains an area of significant unmet medical need in the field of oncology. We are pleased to have the opportunity to collaborate with several key experts in this disease setting."

MORAb-004 is a humanized monoclonal antibody specific for endosialin/TEM-1 protein.  The target is found to be expressed on the cell surface of cells call
'/>"/>

SOURCE Morphotek(R), Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Morphotek®, Inc. Announces Acquisition of Tumor Targeting Assets From Transmolecular, Inc.
2. Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... YORK , Aug. 27, 2014 ... is available in its catalogue: Global ... http://www.reportlinker.com/p02316641/Global-Animal-Health-Market-2014-2018.html About Animal Health Animal ... animal diseases or treat animals to enhance their ... the yield of animal food. The Global Animal ...
(Date:8/27/2014)... Kewaunee Scientific Corporation (Nasdaq: KEQU ... quarterly cash dividend by 9% to twelve cents per ... with the dividend payable on September 22, 2014 to ... September 8, 2014. About Kewaunee Scientific ... Corporation is a recognized global leader in the design, ...
(Date:8/27/2014)... Conn. , Aug. 27, 2014  UBM Medica ... a leading online community for medical imaging professionals, presents ... Association for Medical Imaging Management,s 2014 Annual Meeting . ... conference coverage: , 11 Principles of ... can lead to greater profitability. , Why ...
Breaking Medicine Technology:Global Animal Health Market 2014-2018 2Global Animal Health Market 2014-2018 3Global Animal Health Market 2014-2018 4Global Animal Health Market 2014-2018 5Global Animal Health Market 2014-2018 6Global Animal Health Market 2014-2018 7Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3
... Generex Biotechnology Corporation (Nasdaq: GNBT ; ... diseases through the inner lining of the mouth, announced ... Licensing & Distribution Agreement with PMG S.A. ( www.pmgpharma.com ... Generex Oral-lyn™, the Company,s proprietary buccal insulin spray product, ...
... Corporation, a privately-held biotechnology company focused on developing a ... announced that Quinton Oswald has joined the company as ... significant commercial experience and management expertise to the CEO ... the Vice President & Business Unit Head for the ...
Cached Medicine Technology:Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile 2Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile 3Quinton Oswald Named Chief Executive Officer of SARcode Corporation 2Quinton Oswald Named Chief Executive Officer of SARcode Corporation 3
(Date:8/28/2014)... 28, 2014 Top 10 Best ... hosting companies and announces Bluehost, HostMonster ( http://www.hostmonster.com/track/seohosts ... for the webmasters worldwide who want to buy ... As the world’s most popular server-side scripting language, ... other general-purpose programs. It is now installed on ...
(Date:8/28/2014)... MMAR Medical is pleased to announce their Customer ... customers to enjoy several perks and benefits when shopping ... license. It’s a great choice for independent athletes, high ... regularly purchase medical braces but could use a discounted ... lifestyle or those of your club, group or team, ...
(Date:8/28/2014)... 2014 On September 1st, the National ... campaign. The goal is to help families and ... and effectively and without exposures to risky pesticides. ... “Children’s exposures to pesticides should be limited as ... Head lice are often trivialized in the media, which ...
(Date:8/27/2014)... A St. Louis law firm that represents ... that the C.R. Bard multidistrict litigation (MDL), an MDL ... lawsuits, recently filed a new pretrial order (PTO) on ... discovery process, and more specifically to the management of ... & Lowe is a law firm practicing defective medical ...
(Date:8/27/2014)... August 27, 2014 DentistSave.com ... plans, has launched in the state of Tennessee ... quality, affordable dental care services at reduced rates. ... Tennessee consumers looking to save money on their ... as a member of discount fee dental plan ...
Breaking Medicine News(10 mins):Health News:MMAR Medical Announces Customer Membership Program 2Health News:Head Lice Can Be a Public Health Opportunity 2Health News:Head Lice Can Be a Public Health Opportunity 3Health News:Head Lice Can Be a Public Health Opportunity 4Health News:Carey Danis & Lowe Reports On New Court Order in C.R. Bard Transvaginal Mesh MDL 2Health News:DentistSave.com Launches Discount Dental Plans in Tennessee for Consumers, Businesses, and Groups 2Health News:DentistSave.com Launches Discount Dental Plans in Tennessee for Consumers, Businesses, and Groups 3
... poor balance, dementia, vision loss most in peril, group says ... people are at high risk for accidental falls and should ... fall-related injuries and deaths in the United States, a new ... falls result in 1.8 million emergency room visits and more ...
... NEW YORK, Feb 4 March of Dimes New York ... as the,official Celebrity Chairman for March for Babies(SM) in New ... March of Dimes,premier fundraising event that benefits all babies-those born ... thrive., "I,m proud to be partnering with March of ...
... The Presidents proposed budget for fiscal year 2009, if ... by extension, our national effort to respond to the ... The Administrations budget flat-funds critical federal support for research ... programs at the Centers for Disease Control and Prevention ...
... FY 2009 Budget Blueprint ,Most Unreasonable, Most Unrealistic, ... Reacting to the formal,unveiling of the Bush ... Association (AHCA) said the proposal is unreasonable from ... in the face of worsening economic conditions in ...
... Clinic to Automate Three Offices with High Performance DR ... ... /PRNewswire-FirstCall/ - IDC (Imaging Dynamics Company,Ltd.) (TSX: IDL), the global leader ... a contract by,Orthopaedic Clinic of Daytona Beach in Florida for four ...
... Concludes (Again) That Antitrust Exemptions Increase Costs, ... (PCMA) issued the following statement in response to,the ... (S.B.,2190) that would allow individual and corporate health ... charge higher fees:, "This latest comment from ...
Cached Medicine News:Health News:New Guideline Urges Screening for Fall Risk 2Health News:Eli Manning Teams Up with March of Dimes in New York City 2Health News:2009 Bush budget a disaster for HIV/AIDS 2Health News:Bush Budget Represents 'Double Whammy' Hit on U.S. Seniors' Medicare-Financed Nursing Facility Care 2Health News:Orthopaedic Clinic of Daytona Beach Chooses IDC for Transition to Digital X-ray 2
... an all-in-one drape made of 3M Steri-Drape ... pouch with filter and exit port. It ... inches (164cm) TUR Drape, Absorbent Prevention Fabric, ... cot, Fluid collection pouch with filter and ...
... Both the Penilab IV and the Penilab V have ... Model 1060 is similar to the Model 1061 ... can one be added later. The Penilab V ... all of the accessories you'll need to get started. ...
The Model 240 is a single-channel instrument designed for penile tumescence monitoring. It features exceptional stability. It's ready for use with most multi-channel recorders having a DC input....
... Integra II SP MRI-Compatible Anesthesia System is perfect ... more than one type of anesthetic agent. ... and due to its wider stance, has a ... ventilator bellows assembly is utilized in both the ...
Medicine Products: